Delta 9 Cannabis Inc Share Price Toronto S.E.
Equities
CA2477541049
Pharmaceuticals
Sales 2024 * | 75.8M 55.27M 4.61B | Sales 2025 * | 86.6M 63.14M 5.27B | Capitalization | 8.68M 6.33M 528M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.89% |
Latest transcript on Delta 9 Cannabis Inc
Managers | Title | Age | Since |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01/12/01 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 07/18/07 |
Nitin Kaushal
CHM | Chairman | 58 | 31/17/31 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01/12/01 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 699B | |
+26.29% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+15.13% | 236B | |
+5.05% | 198B | |
-10.31% | 194B | |
-3.69% | 149B |